Braintree Healthcare Limited - Accounts to registrar - small 16.1.1

REGISTERED NUMBER: 03200798 (England and Wales)

Unaudited Financial Statements for the Year Ended 30 April 2016

for

Braintree Healthcare Limited

Page

Company Information

1

Abridged Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

O J Gillie

Dr B N C Sweeney

SECRETARY:

Dr B N C Sweeney

REGISTERED OFFICE:

The Gardens, 1

Crescent Wood Road

London

SE26 6RT

REGISTERED NUMBER:

03200798 (England and Wales)

ACCOUNTANTS:

Thornton Springer LLP

Chartered Accountants

67 Westow Street

Upper Norwood

London

SE19 3RW

FIXED ASSETS

Tangible assets

5

8,895

11,687

CURRENT ASSETS

Stocks

630

670

Debtors: amounts falling due within one year

6

561,697

86,458

Cash at bank and in hand

42,497

524,139

604,824

611,267

CREDITORS

Amounts falling due within one year

7

65,220

178,217

NET CURRENT ASSETS

539,604

433,050

TOTAL ASSETS LESS CURRENT LIABILITIES

548,499

444,737

PROVISIONS FOR LIABILITIES

1,430

1,912

NET ASSETS

547,069

442,825

CAPITAL AND RESERVES

Called up share capital

2

2

Retained earnings

547,067

442,823

SHAREHOLDERS' FUNDS

547,069

442,825

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2016.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2016 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 30 April 2016 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 17 October 2016 and were signed on its behalf by:

Dr B N C Sweeney - Director

1.	STATUTORY INFORMATION

Braintree Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's

registered number and registered office address can be found on the Company Information page.

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. These are the company's first set of financial statements prepared in accordance with FRS 102. There were no transition adjustments.

3.	ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added

tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

10 to 50% Straight line

Computer equipment

-

33% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving

items.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date

where transactions or events that result in an obligation to pay more, or a right to pay less, tax in the future have occurred at

the balance sheet date.

This is subject to deferred tax assets only being recognised if it is considered more likely than not that there will be suitable

profits from which the future reversal of the underlying timing differences can be deducted.

Timing differences are differences arising between the Company's taxable profits and its results as stated in the financial

statements, which are capable of reversal in one or more subsequent periods.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are

charged to profit or loss in the period to which they relate.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 53 .

5.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1 May 2015

and 30 April 2016

100,107

DEPRECIATION

At 1 May 2015

88,420

Charge for year

2,792

At 30 April 2016

91,212

NET BOOK VALUE

At 30 April 2016

8,895

At 30 April 2015

11,687

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.4.16

30.4.15

£

£

Trade debtors

84,147

80,411

Cypress House Gardens

472,114

-

Prepayments

5,436

6,047

561,697

86,458

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.4.16

30.4.15

£

£

Trade creditors

1,905

120,241

Tax

26,543

22,025

Social security and other taxes

8,338

7,781

Other creditors

-

3,094

Directors' loan accounts

4,000

4,000

Accrued expenses

24,434

21,076

65,220

178,217